QQQ   418.19 (-1.23%)
AAPL   165.06 (-1.19%)
MSFT   401.06 (-0.79%)
META   486.51 (-3.05%)
GOOGL   154.45 (-1.00%)
AMZN   176.48 (-1.53%)
TSLA   149.67 (-0.17%)
NVDA   817.55 (-3.44%)
AMD   149.71 (-3.46%)
NIO   3.86 (-3.50%)
BABA   68.80 (-0.12%)
T   16.33 (+0.00%)
F   12.10 (+0.33%)
MU   107.04 (-4.37%)
GE   150.49 (-1.60%)
CGC   8.02 (+2.43%)
DIS   111.68 (-0.67%)
AMC   3.13 (+7.19%)
PFE   25.72 (+1.30%)
PYPL   62.05 (-0.08%)
XOM   119.84 (+1.11%)
QQQ   418.19 (-1.23%)
AAPL   165.06 (-1.19%)
MSFT   401.06 (-0.79%)
META   486.51 (-3.05%)
GOOGL   154.45 (-1.00%)
AMZN   176.48 (-1.53%)
TSLA   149.67 (-0.17%)
NVDA   817.55 (-3.44%)
AMD   149.71 (-3.46%)
NIO   3.86 (-3.50%)
BABA   68.80 (-0.12%)
T   16.33 (+0.00%)
F   12.10 (+0.33%)
MU   107.04 (-4.37%)
GE   150.49 (-1.60%)
CGC   8.02 (+2.43%)
DIS   111.68 (-0.67%)
AMC   3.13 (+7.19%)
PFE   25.72 (+1.30%)
PYPL   62.05 (-0.08%)
XOM   119.84 (+1.11%)
QQQ   418.19 (-1.23%)
AAPL   165.06 (-1.19%)
MSFT   401.06 (-0.79%)
META   486.51 (-3.05%)
GOOGL   154.45 (-1.00%)
AMZN   176.48 (-1.53%)
TSLA   149.67 (-0.17%)
NVDA   817.55 (-3.44%)
AMD   149.71 (-3.46%)
NIO   3.86 (-3.50%)
BABA   68.80 (-0.12%)
T   16.33 (+0.00%)
F   12.10 (+0.33%)
MU   107.04 (-4.37%)
GE   150.49 (-1.60%)
CGC   8.02 (+2.43%)
DIS   111.68 (-0.67%)
AMC   3.13 (+7.19%)
PFE   25.72 (+1.30%)
PYPL   62.05 (-0.08%)
XOM   119.84 (+1.11%)
QQQ   418.19 (-1.23%)
AAPL   165.06 (-1.19%)
MSFT   401.06 (-0.79%)
META   486.51 (-3.05%)
GOOGL   154.45 (-1.00%)
AMZN   176.48 (-1.53%)
TSLA   149.67 (-0.17%)
NVDA   817.55 (-3.44%)
AMD   149.71 (-3.46%)
NIO   3.86 (-3.50%)
BABA   68.80 (-0.12%)
T   16.33 (+0.00%)
F   12.10 (+0.33%)
MU   107.04 (-4.37%)
GE   150.49 (-1.60%)
CGC   8.02 (+2.43%)
DIS   111.68 (-0.67%)
AMC   3.13 (+7.19%)
PFE   25.72 (+1.30%)
PYPL   62.05 (-0.08%)
XOM   119.84 (+1.11%)

Acer Therapeutics (ACER) Earnings Date, Estimates & Call Transcripts

Notice: This company has been marked as potentially delisted and may not be actively trading.
Skip Charts & View Estimated and Actual Earnings Data

ACER Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ACER Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Acer Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/20/2023Q3 2023($0.13)($0.53)($0.40)($0.46)$2.55 million$0.37 million
8/14/2023Q2 2023($0.26)($0.23)+$0.03($0.13)--
5/15/2023Q1 2023($0.29)$1.08+$1.37$1.39--
3/27/2023Q4 2022($0.35)($0.32)+$0.03($0.10)--
11/14/2022Q3 2022($0.76)($0.31)+$0.45($0.31)--
8/15/2022Q2 2022($0.58)($0.48)+$0.10($0.79)--
5/16/2022Q1 2022($0.18)($0.49)($0.31)($0.34)--
3/2/2022Q4 2021($0.08)($0.31)($0.23)($0.31)$5.00 million$0.36 million
11/19/2021Q3 2021($0.28)($0.23)+$0.05($0.23)--
8/9/2021Q2 2021($0.36)($0.23)+$0.13($0.23)--
5/16/2021Q1 2021($0.44)($0.11)+$0.33($0.11)$2.00 million$4.00 million

Acer Therapeutics Earnings - Frequently Asked Questions

How much revenue does Acer Therapeutics generate each year?

Acer Therapeutics (NASDAQ:ACER) has a recorded annual revenue of $1.26 million.

How much profit does Acer Therapeutics generate each year?

Acer Therapeutics (NASDAQ:ACER) has a recorded net income of -$26.24 million. ACER has generated -$0.70 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:ACER) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners